Crowdsourcing as a scientific strategy
NASA's reach extends well beyond launch pads and planetary probes. Through its Center of Excellence for Collaborative Innovation (CoECI), housed within the Space Technology Mission Directorate (STMD), the agency has steadily built a portfolio of open challenges inviting universities, startups, and independent researchers to solve problems that internal teams cannot tackle as quickly — or as creatively — on their own.
Two initiatives spotlighted this week illustrate just how wide that ambition now stretches: one bridges quantum physics and pharmaceutical safety, the other turned a Michigan State engineering student into a drone company founder. Different in scope, they share the same underlying logic — leverage outside talent to multiply impact.
QuSAFE: quantum sensing meets preclinical drug testing
The QuSAFE challenge — short for Quantum-Enabled Predictive Preclinical NAMs for Toxicity and Safety — is a joint effort between NASA and the National Institutes of Health (NIH). Its goal is to harness quantum sensing technologies to strengthen so-called New Approach Methodologies, or NAMs: in vitro systems such as organoids and microphysiological platforms used to evaluate how drugs behave in the body before clinical trials begin.
These lab-grown biological models hold significant promise as alternatives to animal testing, offering the prospect of more predictive, human-relevant data on drug toxicity. The problem, however, is signal quality: the biological outputs these systems generate are often too faint or too noisy for conventional sensors to interpret reliably. Quantum sensing, which can detect extraordinarily subtle physical changes, is being explored as a way to read those signals with far greater precision.
The NASA-NIH pairing is significant in itself. Technologies developed for space applications — quantum sensing has applications in gravitational measurement and navigation — are being deliberately redirected toward biomedical challenges with direct public health consequences. It is an unusually broad form of technology transfer, and one the two agencies appear committed to pushing forward.
From a NASA grant to a drone company
The second story is more personal, but no less instructive. Five years ago, Gavin Gardner was an engineering student at Michigan State University participating in a NASA-funded research grant focused on next-generation unmanned aerial systems. The technical side of the work was demanding, as he expected — but Gardner has said that managing budgets, coordinating with institutional stakeholders, and navigating grant administration proved even more challenging than the engineering itself.
Rather than being discouraged, Gardner absorbed those lessons and channeled them into building his own drone technology venture after graduating. NASA frames his trajectory as a direct product of its university challenge ecosystem — one designed not only to advance research, but to cultivate a generation of technically grounded entrepreneurs capable of commercializing aerospace-adjacent technologies.
The agency's broader pitch is that these programs generate economic value, jobs, and companies, not just academic papers. Gardner's case gives that argument a concrete face.
A model worth watching — and questioning
Taken together, these two initiatives point to a NASA that is actively repositioning itself as an engine of distributed innovation, one willing to fund work in quantum pharmacology or commercial drone development if the underlying technology has roots in aerospace research.
Whether that breadth reflects strategic vision or institutional sprawl is a fair question. For now, the outcomes — a potentially transformative drug safety tool and at least one new aerospace company — suggest the model is producing results. How well it scales, and whether the connections to NASA's core mission remain meaningful, will be worth monitoring in the years ahead.


